- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 5, 2025 | 9.38M sh |
| Short Term Investments | Q3 2025 · Mar 31, 2025 | $10.11M |
| Short Term Investments | Q3 2025 · Jun 30, 2024 | $12.1M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $2.93M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $2.84M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $1.9M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $1.3M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $6.61M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $6.05M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $19.64M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $21.92M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $37.3M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $37.2M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 9.25M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 9.24M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $460.96K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$16.56K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $31.12M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $31.4M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $31.81M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.03 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $1.45M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $4.57M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$313.78K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$840.54K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$609.72K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$1.55M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $841.52K |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $3.02M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $1.8M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $6.35M |